Minzhen Wang

Guangzhou, 510275, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Optimizing Spin Polarization in Spin-LEDs Based on Chiral Perovskites via Material Engineering.

Optimizing Spin Polarization in Spin-LEDs Based on Chiral Perovskites via Material Engineering.

Journal: Nano letters

Published: May 18, 2026

Phosphorylated TYK2 orchestrates the pathogenic program of CD4 + T cells in the development of CNS autoimmunity.

Phosphorylated TYK2 orchestrates the pathogenic program of CD4 + T cells in the development of CNS autoimmunity.

Journal: Journal of neuroinflammation

Published: March 26, 2026

Corrigendum to Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis.

Corrigendum to Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis.

Journal: JCI insight

Published: January 02, 2026

Novel insights of minocycline as a neurovascular protective agent in retinitis pigmentosa.

Novel insights of minocycline as a neurovascular protective agent in retinitis pigmentosa.

Journal: The British journal of ophthalmology

Published: August 10, 2025

Inhibition of bruton's tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis.

Inhibition of bruton's tyrosine kinase directly alleviates pathogenic CD4+ T cell response via PPAR-γ signaling in autoimmune uveitis.

Journal: Journal of neuroinflammation

Published: May 29, 2025

STING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis.

STING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis.

Journal: Investigative ophthalmology & visual science

Published: March 05, 2025

miR142 silencing alleviates retinal inflammation by impairing mitochondrial function and reprogramming metabolism of CD4+ T cells via targeting MTFR1.

miR142 silencing alleviates retinal inflammation by impairing mitochondrial function and reprogramming metabolism of CD4+ T cells via targeting MTFR1.

Journal: International immunopharmacology

Published: December 07, 2024

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial.

Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial.

Journal: Signal transduction and targeted therapy

Published: June 24, 2024

Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis.

Neutrophil extracellular traps potentiate effector T cells via endothelial senescence in uveitis.

Journal: JCI insight

Published: February 12, 2024

An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease.

An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease.

Journal: Eye and vision (London, England)

Published: January 12, 2024

Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis.

Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis.

Journal: International immunopharmacology

Published: January 05, 2024

Circadian Rhythm Disruption Exacerbates Autoimmune Uveitis: The Essential Role of PER1 in Treg Cell Metabolic Support for Stability and Function.

Circadian Rhythm Disruption Exacerbates Autoimmune Uveitis: The Essential Role of PER1 in Treg Cell Metabolic Support for Stability and Function.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 01, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026